RxSight, Inc. to Present at the Bank of America Healthcare Conference
RxSight, Inc. (NASDAQ: RXST), a company focused on advanced ophthalmic medical devices, is set to present at the Bank of America Healthcare Conference on May 10, 2023, at 3:55 PM PT / 6:55 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight, Inc. (NASDAQ: RXST), a company focused on advanced ophthalmic medical devices, is set to present at the Bank of America Healthcare Conference on May 10, 2023, at 3:55 PM PT / 6:55 PM ET. The presentation will focus on their innovative RxSight® Light Adjustable Lens system, which enhances vision after cataract surgery by allowing adjustments post-operatively. This system includes the RxSight Light Adjustable Lens® and the Light Delivery Device (LDD™), marking it as the first adjustable intraocular lens technology available. Interested stakeholders can access the live and archived webcast of the presentation via the company’s investor relations website.
Details
News Market Reaction – RXST
The recorded move for RXST in the trading session of this news was +4.82%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference.
RxSight’s management is scheduled to present on Wednesday, May 10, 2023, at 3:55 p.m. Pacific Time / 6:55 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery enabling doctors to customize and deliver high-quality of vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley Thunen
RxSight, Inc.
949-521-7830
sthunen@rxsight.com
Investor Relations Contact:
ir@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.